KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals is a clinical-stage biotech company developing oral therapies for rare diseases like hereditary angioedema (HAE). Its growth is driven by promising clinical trial data, a focus on unmet medical needs, and a lead candidate designed to simplify treatment. The company aims to bring safer, more convenient options to underserved patient populations. Chart
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals focuses on developing and commercializing treatments for rare pediatric diseases. The company’s pipeline includes approved and late-stage products addressing critical gaps in pediatric care. Growth is supported by market exclusivity, licensing partnerships, and expanding commercial reach in specialized health markets. Chart
Follow Trade Ideas on 